Comparison 7. Number of cycles of taxane‐containing chemotherapy.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Overall survival	25		Hazard Ratio (95% CI)	Subtotals only
1.1 3 cycles of taxane	7	6551	Hazard Ratio (95% CI)	0.77 [0.69, 0.86]
1.2 4 or more cycles of taxane	19	29458	Hazard Ratio (95% CI)	0.91 [0.86, 0.96]
2 Disease‐free survival	28		Hazard Ratio (95% CI)	Subtotals only
2.1 3 cycles of taxane	7	6551	Hazard Ratio (95% CI)	0.80 [0.73, 0.88]
2.2 4 or more cycles of taxane	22	32187	Hazard Ratio (95% CI)	0.91 [0.87, 0.95]